US FDA Approves ARAKODA (tafenoquine) tablets for oral use, first preventative antimalarial approved in almost two decades
21st August, 2018
CONTACT US
For help or more information, please don't hesitate to contacts us:
​
Registered Australian Office:
Biocelect Pty Ltd
Level 4, 51 Rawson Street, Epping NSW 2121, Australia
Registered New Zealand Office:
Biocelect New Zealand Limited
Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand
General Inquiries: 1300 907 411
​
To report a suspected side effect by a Biocelect
Pharmaceutical Drug or Vaccine: 1300 848 628